XORTX Therapeutics Inc (XRTX)
2.65
-0.03
(-1.01%)
USD |
NASDAQ |
May 06, 16:00
2.65
0.00 (0.00%)
After-Hours: 20:00
XORTX Therapeutics Price to Book Value: 1.655 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 1.672 |
May 02, 2024 | 1.623 |
May 01, 2024 | 1.600 |
April 30, 2024 | 1.592 |
April 29, 2024 | 1.652 |
April 26, 2024 | 1.830 |
April 25, 2024 | 1.617 |
April 24, 2024 | 1.812 |
April 23, 2024 | 1.836 |
April 22, 2024 | 1.873 |
April 19, 2024 | 1.872 |
April 18, 2024 | 1.905 |
April 17, 2024 | 1.979 |
April 16, 2024 | 1.936 |
April 15, 2024 | 2.011 |
April 12, 2024 | 2.098 |
April 11, 2024 | 2.220 |
April 10, 2024 | 2.194 |
April 09, 2024 | 2.379 |
April 08, 2024 | 2.438 |
April 05, 2024 | 2.310 |
April 04, 2024 | 2.204 |
April 03, 2024 | 2.029 |
April 02, 2024 | 2.107 |
April 01, 2024 | 2.273 |
Date | Value |
---|---|
March 28, 2024 | 2.310 |
March 27, 2024 | 2.248 |
March 26, 2024 | 2.373 |
March 25, 2024 | 2.388 |
March 22, 2024 | 2.779 |
March 21, 2024 | 3.020 |
March 20, 2024 | 2.741 |
March 19, 2024 | 3.091 |
March 18, 2024 | 3.028 |
March 15, 2024 | 3.228 |
March 14, 2024 | 3.378 |
March 13, 2024 | 3.097 |
March 12, 2024 | 3.016 |
March 11, 2024 | 2.779 |
March 08, 2024 | 2.978 |
March 07, 2024 | 2.879 |
March 06, 2024 | 3.903 |
March 05, 2024 | 2.997 |
March 04, 2024 | 2.148 |
March 01, 2024 | 1.992 |
February 29, 2024 | 1.849 |
February 28, 2024 | 2.029 |
February 27, 2024 | 1.666 |
February 26, 2024 | 1.697 |
February 23, 2024 | 1.466 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6601
Minimum
Dec 28 2023
579.03
Maximum
Jul 30 2019
13.78
Average
1.968
Median
Price to Book Value Benchmarks
ImmunoPrecise Antibodies Ltd | 0.9204 |
Acasti Pharma Inc | 0.4287 |
Aurinia Pharmaceuticals Inc | 1.951 |
Edesa Biotech Inc | 2.485 |
Lexaria Bioscience Corp | 6.580 |
Price to Book Value Related Metrics
Price | 2.65 |
Earnings Yield | -41.89% |
Market Cap | 7.681M |